Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Matrix-M

Vaccines

Vaccines Today—May 8, 2026

This weekly update in vaccines and immunotherapy covers recent developments…

Vaccines

Vaccines Today—January 23, 2026

This week’s updates cover key advancements in clinical trials, regulatory…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
LucidWargames
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Immunology Today—June 17, 2026
Neuroscience Today—June 17, 2026
Endocrinology Today—June 16, 2026
Obesity Today—June 16, 2026
Lonza Antharis Dual-Payload ADC License | Lucid Diligence Brief

Tags

ABS-1230 Acute Decompensated Heart Failure Ajax Therapeutics alpha-thalassemia AMWC Dubai Breztri Aerosphere C4 Therapeutics Cenrifki Chance Pharma Cigna coverage COVID-19 variants CryptiVax-1001 CTNNB1S37F DB104 Delpacibart Braxlosiran Diabetic retinopathy DMD exon 51 efdoralprin alfa Endeavor BioMedicines Epstein-Barr Virus-Positive NK/T-Cell Lymphoma Garmin GC Cell Immune-Mediated Inflammatory Skin Diseases Leber Congenital Amaurosis Type 5 Nutrition behavior ofatumumab Parexel Parkway Radiology PCV13 booster PDPL Pelareorep Plus Therapeutics R9 recombinases Relapsed Or Refractory B-Cell Non-Hodgkin Lymphoma Relief Cardiovascular Semble SiranBio STAR-101 supercomputing Taiho Oncology TranC University of Colorado Anschutz Gates Institute Verily warrants

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Immunology Today—June 17, 2026
Neuroscience Today—June 17, 2026
Endocrinology Today—June 16, 2026
Obesity Today—June 16, 2026
Lonza Antharis Dual-Payload ADC License | Lucid Diligence Brief

TAGS

ABS-1230 Acute Decompensated Heart Failure Ajax Therapeutics alpha-thalassemia AMWC Dubai Breztri Aerosphere C4 Therapeutics Cenrifki Chance Pharma Cigna coverage COVID-19 variants CryptiVax-1001 CTNNB1S37F DB104 Delpacibart Braxlosiran Diabetic retinopathy DMD exon 51 efdoralprin alfa Endeavor BioMedicines Epstein-Barr Virus-Positive NK/T-Cell Lymphoma Garmin GC Cell Immune-Mediated Inflammatory Skin Diseases Leber Congenital Amaurosis Type 5 Nutrition behavior ofatumumab Parexel Parkway Radiology PCV13 booster PDPL Pelareorep Plus Therapeutics R9 recombinases Relapsed Or Refractory B-Cell Non-Hodgkin Lymphoma Relief Cardiovascular Semble SiranBio STAR-101 supercomputing Taiho Oncology TranC University of Colorado Anschutz Gates Institute Verily warrants

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy